The efficacy of oligonucleotide chip detecting YMDD mutants of hepatitis B virus in lamivudine-treated patients.

被引：0
|
作者：
Heo, J
Cho, M
Kim, GH
Kang, DH
Song, GA
Yang, US
Jang, HJ
Park, HK
Kim, CM
Kim, HH
Cho, BM
Shin, WW
机构：
[1] Pusan Natl Univ, Coll Med, Pusan, South Korea
[2] Pusan Natl Univ, Coll Nat Sci, Pusan, South Korea
[3] Donga Univ, Coll Med, Pusan, South Korea
来源：
HEPATOLOGY | 2003年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1163
引用
收藏
页码：716A / 717A
页数：2
相关论文
共 50 条
  • [1] Clinical significance of YMDD mutant hepatitis B virus (HBV) in a large cohort of lamivudine-treated hepatitis B patients.
    Atkins, M
    Hunt, CM
    Brown, N
    Gray, F
    Sanathanan, L
    Woessner, M
    Lai, CL
    Dusheiko, G
    Dienstag, J
    Wright, T
    Barnard, J
    Bourne, E
    Condreay, L
    HEPATOLOGY, 1998, 28 (04) : 319A - 319A
  • [2] Dynamic changes of hepatitis B virus polymerase gene including YMDD motif in lamivudine-treated patients with chronic hepatitis B
    Feng, Bo
    Wei, Lai
    Chen, Ming
    Wang, Liping
    MICROBIOLOGICAL RESEARCH, 2008, 163 (04) : 487 - 492
  • [3] The emergence of YMDD mutants precedes biochemical flare by 19 weeks in lamivudine-treated chronic hepatitis B patients: an opportunity for therapy reevaluation
    Franca, P. H. C.
    Coelho, H. S. M.
    Brandao, C. E.
    Segadas, J. A.
    Quintaes, R. F.
    Carrilho, F. J.
    Ono-Nita, S.
    Mattos, A. A.
    Tovo, C.
    Gouvea, V. S.
    Sablon, E.
    Vanderborght, B. O. M.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2007, 40 (12) : 1605 - 1614
  • [4] Detection of YMDD motif mutants by oligonucleotide chips in lamivudine-untreated patients with chronic hepatitis B virus infection
    Heo, J
    Cho, M
    Kim, HH
    Shin, YM
    Jang, HJ
    Park, HK
    Kim, CM
    Kim, GH
    Kang, DH
    Song, GA
    Yang, US
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2004, 19 (04) : 541 - 546
  • [5] Early detection and quantification of lamivudine-resistant hepatitis B virus mutants by fluorescent biprobe hybridization assay in lamivudine-treated patients
    Umeoka, Fumi
    Iwasaki, Yoshiaki
    Matsumura, Masayuki
    Takaki, Akinobu
    Kobashi, Haruhiko
    Tatsukawa, Masashi
    Shiraha, Hidenori
    Fujioka, Shin-ichi
    Sakaguchi, Kohsaku
    Shiratori, Yasushi
    JOURNAL OF GASTROENTEROLOGY, 2006, 41 (07) : 693 - 701
  • [6] Early detection and quantification of lamivudine-resistant hepatitis B virus mutants by fluorescent biprobe hybridization assay in lamivudine-treated patients
    Fumi Umeoka
    Yoshiaki Iwasaki
    Masayuki Matsumura
    Akinobu Takaki
    Haruhiko Kobashi
    Masashi Tatsukawa
    Hidenori Shiraha
    Shin-ichi Fujioka
    Kohsaku Sakaguchi
    Yasushi Shiratori
    Journal of Gastroenterology, 2006, 41 : 693 - 701
  • [7] YMDD motif mutants in hepatitis B virus polymerase during lamivudine therapy
    Han, JH
    Hwang, SG
    Chung, KW
    Oh, SW
    Hong, SP
    Park, PW
    Rim, KS
    Oh, D
    Kim, NK
    KOREAN JOURNAL OF GENETICS, 2002, 24 (02): : 219 - 226
  • [8] Emergence of YMDD motif mutants of hepatitis B virus during lamivudine treatment of immunocompetent type B hepatitis patients
    Seta, T
    Yokosuka, O
    Imazeki, F
    Tagawa, M
    Saisho, H
    JOURNAL OF MEDICAL VIROLOGY, 2000, 60 (01) : 8 - 16
  • [9] Serum hepatitis B surface antigen monitoring in long-term lamivudine-treated hepatitis B virus patients
    Gramenzi, A.
    Loggi, E.
    Micco, L.
    Cursaro, C.
    Fiorino, S.
    Galli, S.
    Gitto, S.
    Galli, C.
    Furlini, G.
    Bernardi, M.
    Andreone, P.
    JOURNAL OF VIRAL HEPATITIS, 2011, 18 (10) : E468 - E474
  • [10] Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance
    Hsu, Chao-Wei
    Yeh, Chau-Ting
    Chang, Ming-Ling
    Liaw, Yun-Fan
    GASTROENTEROLOGY, 2007, 132 (02) : 543 - 550
12345